LISATA THERAPEUTICS INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
LSTA$1.02-8.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2024 and 2023
Index'
(In thousands, except share data)
| December 31,2024 | December 31,2023 | |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $16,209 | $22,593 |
| Marketable securities | 15,036 | 27,942 |
| Accounts receivable | 900 | — |
| Prepaid and other current assets | 2,433 | 3,389 |
| Total current assets | 34,578 | 53,924 |
| Property and equipment, net | 72 | 175 |
| Acquired license-intangible, net | 192 | 263 |
| Other assets | 160 | 332 |
| Total assets | $35,002 | $54,694 |
| LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY | ||
| Liabilities | ||
| Accounts payable | $1,284 | $2,421 |
| Accrued liabilities | 4,329 | 4,169 |
| Total current liabilities | 5,613 | 6,590 |
| Other long-term liabilities | 72 | 210 |
| Total liabilities | 5,685 | 6,800 |
| Commitments and Contingencies (Note 14) | ||
| Stockholders' Equity | ||
| Common stock, $0.001 par value, authorized 500,000,000 shares; issued 8,409,582 and 8,150,635 shares, at December 31, 2024 and December 31, 2023, respectively; and outstanding, 8,408,844 and 8,149,897 shares, at December 31, 2024 and December 31, 2023, respectively | 8 | 8 |
| Additional paid-in capital | 578,418 | 576,971 |
| Treasury stock, at cost; 738 shares at December 31, 2024 and December 31, 2023 respectively | (708) | (708) |
| Accumulated deficit | (548,066) | (528,081) |
| Accumulated other comprehensive loss | (81) | (42) |
| Total Lisata Therapeutics, Inc. stockholders' equity | 29,571 | 48,148 |
| Non-controlling interests | (254) | (254) |
| Total equity | 29,317 | 47,894 |
| Total liabilities, non-controlling interests and stockholders' equity | $35,002 | $54,694 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.